Egetis Therapeutics Board Issues Statement on ANI Pharma Cash Offer
Egetis Therapeutics said its board issued a statement concerning ANI Pharmaceuticals’ public cash offer.
Story updates
06:15:54 AM UTC
SquawkNews
EGETIS THERAPEUTICS AB (PUBL) - PRICE PER SHARE IN OFFER REPRESENTS A PREMIUM OF ABOUT 12.6% COMPARE